Details for New Drug Application (NDA): 071618
✉ Email this page to a colleague
NDA 071618 describes RITODRINE HYDROCHLORIDE, which is a drug marketed by Abraxis Pharm and Hospira and is included in five NDAs. Additional details are available on the RITODRINE HYDROCHLORIDE profile page.
The generic ingredient in RITODRINE HYDROCHLORIDE is ritodrine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the ritodrine hydrochloride profile page.
The generic ingredient in RITODRINE HYDROCHLORIDE is ritodrine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the ritodrine hydrochloride profile page.
Summary for 071618
| Tradename: | RITODRINE HYDROCHLORIDE |
| Applicant: | Hospira |
| Ingredient: | ritodrine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 071618
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
| Approval Date: | Feb 28, 1991 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
